paclitaxel has been researched along with Allergic Reaction in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 8 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banerji, A; Blumenthal, KG; Cogan, AS; McMahon, AE; Robinson, LB; Saff, RR; Wolfson, AR | 1 |
| Aicher, SA; Blum, C; Hamity, MV; Hammond, DL; Hegarty, DM; Kolker, SJ; Langmack, L | 1 |
| Ichikawa, G; Nakanishi, K; Okazaki, S; Suzuki, S | 1 |
| Ahuja, A; Khurana, A; Rani, S; Sachdeva, S; Sardana, K; Savitha, B | 1 |
| Abelé, M; Aelbrecht-Meurisse, C; Carnot, A; Feutry, F; Gaboriau, L; Le Deley, MC; Léguillette, C; Marliot, G; Sakji, I; Strobbe, G; Villain, A | 1 |
| Akbarali, HI; Damaj, MI; Jessup, D; Thakker, S; Woods, K | 1 |
| Cheng, MH; Chou, PL; Fang, YP; Huang, YP; Rau, KM | 1 |
| Cannita, K; Cocciolone, V; Cortellini, A; Ficorella, C; Lanfiuti Baldi, P; Palluzzi, E; Parisi, A; Porzio, G; Sidoni, T | 1 |
| Alexandre, J; Emile, G; Gataa, I; Goldwasser, F; Loriot, MA | 1 |
| Ladich, E; Nakazawa, G; Virmani, R | 1 |
| Goudevenos, JA; Kounis, NG | 1 |
| Giannopoulos, S; Goudevenos, JA; Kounis, NG | 1 |
| Guo, RF; Jin, DJ; Liu, YL; Wang, RY; Xia, XJ; Zhang, PX; Zhou, CP | 1 |
| Ishii, T; Kawashima, T; Kouyama, Y; Masaka, T; Matsuzawa, Y; Muto, S; Okuno, H; Shirai, K; Yokoyama, Y | 1 |
| Chen, W; Cheng, G; Du, Y; Fu, F; Tian, J; Wang, H; Wang, T; Ye, L; Zhang, L | 1 |
| Goromaru, T; Hirakawa, T; Ishida, M; Itoh, Y; Nakano, H; Oishi, R; Sendo, T | 1 |
| Farb, A; Guagliumi, G; Kolodgie, FD; Virmani, R | 1 |
| Azarbal, B; Currier, JW | 1 |
| Duchateau, J; Jaziri, M; Vanhaelen, M; Vanhaelen-Fastré, R | 1 |
2 review(s) available for paclitaxel and Allergic Reaction
| Article | Year |
|---|---|
Improvement of Paclitaxel-Associated Adverse Reactions (ADRs) via the Use of Nano-Based Drug Delivery Systems: A Systematic Review and Network Meta-Analysis.
Topics: Drug Delivery Systems; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hypersensitivity; Male; Middle Aged; Nanoparticles; Network Meta-Analysis; Paclitaxel | 2020 |
Drug-eluting stents: caution and concerns for long-term outcome.
Topics: Animals; Coronary Restenosis; Device Approval; Humans; Hypersensitivity; Immunosuppressive Agents; Paclitaxel; Polymers; Sirolimus; Stents; Thrombosis; United States; Wound Healing | 2004 |
1 trial(s) available for paclitaxel and Allergic Reaction
| Article | Year |
|---|---|
First-line carboplatin/nab-paclitaxel in advanced ovarian cancer patients, after hypersensitivity reaction to solvent-based taxanes: a single-institution experience.
Topics: Adult; Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Follow-Up Studies; Humans; Hypersensitivity; Male; Middle Aged; Ovarian Neoplasms; Paclitaxel; Prognosis; Retrospective Studies; Solvents; Taxoids | 2020 |
17 other study(ies) available for paclitaxel and Allergic Reaction
| Article | Year |
|---|---|
COVID-19 vaccines tolerated in patients with paclitaxel and docetaxel allergy.
Topics: COVID-19; COVID-19 Vaccines; Docetaxel; Humans; Hypersensitivity; Paclitaxel; SARS-CoV-2 | 2022 |
Nicotinamide Riboside Alleviates Corneal and Somatic Hypersensitivity Induced by Paclitaxel in Male Rats.
Topics: Animals; Corneal Diseases; Disease Models, Animal; Hypersensitivity; Male; Niacinamide; Paclitaxel; Rats; Rats, Sprague-Dawley; Tears; Vitamin B Complex | 2022 |
Allergy testing for Cremophor in a patient with cervical cancer with infusion reactions to paclitaxel and docetaxel.
Topics: Docetaxel; Female; Humans; Hypersensitivity; Paclitaxel; Polyethylene Glycols; Taxoids; Uterine Cervical Neoplasms | 2022 |
Case Report: Chemoradiation with Paclitaxel and Carboplatin Unveiling Leprosy Type 1 Downgrading Reaction.
Topics: Carboplatin; Humans; Hypersensitivity; Leprosy; Paclitaxel; Peripheral Nervous System Diseases | 2022 |
Impact of histamine-2 antagonist shortage on the incidence of hypersensitivity reactions to paclitaxel: a reconsideration of premedication protocols in France (PACLIREACT Study).
Topics: Antineoplastic Agents, Phytogenic; Dexamethasone; Drug Hypersensitivity; Histamine; Histamine Antagonists; Humans; Hypersensitivity; Incidence; Paclitaxel; Premedication; Ranitidine; Retrospective Studies | 2023 |
Short-chain fatty acid, butyrate prevents morphine-and paclitaxel-induced nociceptive hypersensitivity.
Topics: Analgesics, Opioid; Animals; Butyrates; Ganglia, Spinal; Hyperalgesia; Hypersensitivity; Mice; Morphine; Nociception; Paclitaxel; Quality of Life | 2023 |
Association between high antitumor activity of oxaliplatin and cyclophosphamide and constitutional GSTM1 homozygous deletion in an advanced ovarian cancer patient.
Topics: Alleles; Antineoplastic Agents; Carboplatin; Cyclophosphamide; Female; Gene Deletion; Glutathione Transferase; Homozygote; Humans; Hypersensitivity; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Paclitaxel; Recurrence | 2013 |
Drug-eluting coronary stents: many meta-analyses, little benefit.
Topics: Angina, Unstable; Angioplasty, Balloon; Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Bypass; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Humans; Hypersensitivity; Meta-Analysis as Topic; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Sirolimus; Thrombosis; Ticlopidine; Treatment Outcome | 2009 |
Are drug-eluting stents safe?: Definitely! Or probably... possibly? Or maybe not yet....
Topics: Alloys; Cardiovascular Agents; Clinical Trials as Topic; Coronary Restenosis; Drug-Eluting Stents; Humans; Hypersensitivity; Incidence; Paclitaxel; Platelet Aggregation Inhibitors; Risk Factors; Sirolimus; Thrombosis; Time Factors | 2009 |
Everolimus-eluting versus paclitaxel-eluting stents.
Topics: Drug-Eluting Stents; Equipment Design; Everolimus; Humans; Hypersensitivity; Immunosuppressive Agents; Nickel; Paclitaxel; Sirolimus; Thrombosis | 2010 |
The Kounis syndrome in everolimus-eluting stents and paclitaxel-eluting stents.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Drug-Eluting Stents; Everolimus; Humans; Hypersensitivity; Myocardial Infarction; Paclitaxel; Prosthesis Design; Sirolimus; Syndrome; Thrombosis; Treatment Outcome | 2010 |
Formulation, characterization and hypersensitivity evaluation of an intravenous emulsion loaded with a paclitaxel-cholesterol complex.
Topics: Animals; Antineoplastic Agents, Phytogenic; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Cholesterol; Drug Carriers; Drug Stability; Emulsions; Glycerol; Guinea Pigs; Hydrogen-Ion Concentration; Hypersensitivity; Injections, Intravenous; Osmolar Concentration; Paclitaxel; Particle Size; Plant Lectins; Poloxamer; Soybean Oil; Soybean Proteins; Triglycerides | 2011 |
Development of an enzyme-linked immunosorbent assay system to determine the presence of antibodies specific for taxane structures.
Topics: Animals; Antibodies; Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Cattle; Enzyme-Linked Immunosorbent Assay; Fungi; Humans; Hypersensitivity; Mice; Neoplasms; Paclitaxel; Phytotherapy; Risk Factors; Taxoids; Taxus | 2011 |
Hypersensitivity reaction studies of a polyethoxylated castor oil-free, liposome-based alternative paclitaxel formulation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Castor Oil; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Complement Activation; Complement Membrane Attack Complex; Complement System Proteins; Enzyme-Linked Immunosorbent Assay; Histamine; Humans; Hypersensitivity; Liposomes; Lung; Mice; Neoplasms; Paclitaxel | 2013 |
Role of substance P in hypersensitivity reactions induced by paclitaxel, an anticancer agent.
Topics: Animals; Antineoplastic Agents; Bronchoalveolar Lavage Fluid; Female; Histamine; Humans; Hypersensitivity; Indoles; Male; Neurokinin-1 Receptor Antagonists; Ovarian Neoplasms; Paclitaxel; Piperidines; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Retrospective Studies; Substance P | 2004 |
Allergic reactions after the implantation of drug-eluting stents: is it the pill or the polymer?
Topics: Coronary Vessels; Drug Hypersensitivity; Humans; Hypersensitivity; Paclitaxel; Sirolimus; Stents | 2006 |
Taxanes in Taxus baccata pollen: cardiotoxicity and/or allergenicity?
Topics: Alkaloids; Animals; Antibodies, Anti-Idiotypic; Antineoplastic Agents, Phytogenic; Drugs, Chinese Herbal; Enzyme-Linked Immunosorbent Assay; Humans; Hypersensitivity; Immunoglobulin G; Male; Mice; Paclitaxel; Plant Extracts; Plant Leaves; Pollen; Taxoids; Taxus; Toxicity Tests, Acute | 2002 |